Medtronic Inc. said a Danish study to be presented tomorrow at a cardiac conference may have been “biased against” its Endeavor drug-coated stent in favor of a rival artery-clearing device from Johnson & Johnson.

See the original post:
Medtronic Says Heart-Stent Study May Have Favored Rival Device